Twist Bioscience Corp. (TWST)

27.09
NASDAQ : Health Technology
Prev Close 28.00
Day Low/High 26.85 / 28.06
52 Wk Low/High 12.38 / 35.95
Avg Volume 312.60K
Exchange NASDAQ
Shares Outstanding 32.56M
Market Cap 911.65M
EPS -2.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Twist Bioscience Launches Long Oligos To Fuel Drug Development, DNA Data Storage And Gene Editing Research

Twist Bioscience Launches Long Oligos To Fuel Drug Development, DNA Data Storage And Gene Editing Research

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of its long oligonucleotides, or oligos, product line.

Twist Bioscience Enhances DNA Storage Capabilities Through Agreement With Imagene SA

Twist Bioscience Enhances DNA Storage Capabilities Through Agreement With Imagene SA

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has entered into an agreement with Imagene SA, where Imagene will...

Twist Bioscience To Report Fiscal 2019 Third Quarter Financial Results On Thursday, August 1, 2019

Twist Bioscience To Report Fiscal 2019 Third Quarter Financial Results On Thursday, August 1, 2019

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that it will issue its financial results for the fiscal 2019 third quarter ended June 30, 2019,...

Twist Bioscience Launches Mouse Exome To Power Genetic Research

Twist Bioscience Launches Mouse Exome To Power Genetic Research

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of the Twist Mouse Core Exome Panel, the most comprehensive,...

Twist Bioscience To Present At The Jefferies 2019 Global Healthcare Conference

Twist Bioscience To Present At The Jefferies 2019 Global Healthcare Conference

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.

Twist Bioscience Strengthens Board With Semiconductor And Storage Expert Nelson C. Chan

Twist Bioscience Strengthens Board With Semiconductor And Storage Expert Nelson C. Chan

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it appointed Nelson C.

Collaboration Of Four Biotech Companies Showcases High Throughput DNA Assembly Platform For Diverse Applications

Collaboration Of Four Biotech Companies Showcases High Throughput DNA Assembly Platform For Diverse Applications

Arzeda, the Protein Design Company™, Twist Bioscience Corporation (Nasdaq: TWST), TeselaGen Biotechnology Inc.

How Much China?: Cramer's 'Mad Money' Recap (Wednesday 5/22/19)

How Much China?: Cramer's 'Mad Money' Recap (Wednesday 5/22/19)

This market can be judged on how much exposure a stock has to China and trade war risks. Jim Cramer starts with Apple.

Honda, Ford, Toyota, Twist Bioscience: 'Mad Money' Lightning Round

Honda, Ford, Toyota, Twist Bioscience: 'Mad Money' Lightning Round

Jim Cramer weighs in on Honda, Ford, Toyota, Twist Bioscience, Vipshop, Marathon Petroleum, JetBlue Airways, Coty, BGC Partners and more.

Twist Bioscience To Present At The UBS Global Healthcare Conference

Twist Bioscience To Present At The UBS Global Healthcare Conference

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.

Twist Bioscience Announces Closing Of Upsized Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares

Twist Bioscience Announces Closing Of Upsized Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the closing of its upsized underwritten public offering of 4,312,500 shares...

Twist Bioscience Announces Pricing Of $78.8 Million Public Offering Of Common Stock

Twist Bioscience Announces Pricing Of $78.8 Million Public Offering Of Common Stock

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the pricing of its underwritten public offering of 3,750,000 shares of its...

Twist Bioscience Announces Proposed Public Offering Of Common Stock

Twist Bioscience Announces Proposed Public Offering Of Common Stock

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has commenced an underwritten public offering of 3,000,000 shares...

Twist Bioscience Reports Second Quarter Fiscal 2019 Financial Results And Highlights Commercial And Operational Progress

Twist Bioscience Reports Second Quarter Fiscal 2019 Financial Results And Highlights Commercial And Operational Progress

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the second quarter of fiscal...

Twist Bioscience Announces Synthetic DNA Biosecurity Publication In Frontiers

Twist Bioscience Announces Synthetic DNA Biosecurity Publication In Frontiers

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a new biosecurity publication titled 'Next Steps for Access to Safe, Secure...

Twist Bioscience To Report Fiscal 2019 Second Quarter Financial Results On Tuesday, April 30, 2019

Twist Bioscience To Report Fiscal 2019 Second Quarter Financial Results On Tuesday, April 30, 2019

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that it will issue its financial results for the fiscal 2019 second quarter ended March 31, 2019,...

Twist Bioscience And IGEM Partner To Provide Synthetic DNA For IGEM Competition And Registry

Twist Bioscience And IGEM Partner To Provide Synthetic DNA For IGEM Competition And Registry

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and the International Genetically Engineered Machine (iGEM) Foundation today announced a...

Twist Bioscience Announces Antibody Optimization Agreement With Pandion Therapeutics

Twist Bioscience Announces Antibody Optimization Agreement With Pandion Therapeutics

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a new collaboration with Pandion Therapeutics, to apply its antibody...

Twist Bioscience Customized Libraries For Biologics Discovery Highlighted At PEGS Boston 2019

Twist Bioscience Customized Libraries For Biologics Discovery Highlighted At PEGS Boston 2019

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the presentation of four posters at PEGS (The Essential Protein Engineering...

Twist Bioscience Adopts Battelle's ThreatSEQ™ DNA Screening Web Service For Advanced Biosecurity

Twist Bioscience Adopts Battelle's ThreatSEQ™ DNA Screening Web Service For Advanced Biosecurity

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it is the first to implement Battelle's ThreatSEQ™ web service DNA...

Twist Bioscience And LakePharma Form Strategic Collaboration To Provide Antibody Discovery And Development Services

Twist Bioscience And LakePharma Form Strategic Collaboration To Provide Antibody Discovery And Development Services

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and LakePharma, Inc.

Twist Bioscience Announces Presentations And User Group Meeting At PEGS Boston 2019

Twist Bioscience Announces Presentations And User Group Meeting At PEGS Boston 2019

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced five presentations at PEGS (The Essential Protein Engineering Summit)...

Twist Bioscience To Present At Cowen 39th Annual Healthcare Conference

Twist Bioscience To Present At Cowen 39th Annual Healthcare Conference

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.

Twist's Enhanced NGS Target Enrichment Product Line, Available To Early Access Customers, Can Offer Dramatic Time Savings By Accelerating Hybridization To As Little As 15 Minutes. (Graphic: Business Wire)

Twist's Enhanced NGS Target Enrichment Product Line, Available To Early Access Customers, Can Offer Dramatic Time Savings By Accelerating Hybridization To As Little As 15 Minutes. (Graphic: Business Wire)

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the availability of new product solutions for its Twist Human Core Exome...

Twist Bioscience Reports First Quarter Fiscal 2019 Financial Results And Highlights Commercial And Operational Progress

Twist Bioscience Reports First Quarter Fiscal 2019 Financial Results And Highlights Commercial And Operational Progress

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the first quarter of fiscal...

Twist Bioscience Announces Appointment Of Martin Kunz As Senior Vice President, Operations

Twist Bioscience Announces Appointment Of Martin Kunz As Senior Vice President, Operations

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA manufactured on its silicon platform, today announced the appointment of Martin Kunz as senior vice president of...

Twist Bioscience Chief Technology Officer Presented At Praesens Foundation Future Health Threats Initiative 2019

Twist Bioscience Chief Technology Officer Presented At Praesens Foundation Future Health Threats Initiative 2019

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that Bill Peck, Ph.

Twist Bioscience To Report Fiscal 2019 First Quarter Financial Results On Thursday, February 7, 2019

Twist Bioscience To Report Fiscal 2019 First Quarter Financial Results On Thursday, February 7, 2019

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that it will issue its financial results for the fiscal 2019 first quarter ended December 31, 2018,...